Published in Bone on May 08, 2007
New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol (2011) 3.97
Pathways in external apical root resorption associated with orthodontia. Orthod Craniofac Res (2009) 0.90
Domain of dentine sialoprotein mediates proliferation and differentiation of human periodontal ligament stem cells. PLoS One (2013) 0.85
Bis-enoxacin inhibits bone resorption and orthodontic tooth movement. J Dent Res (2013) 0.83
Selective β2-adrenergic Antagonist Butoxamine Reduces Orthodontic Tooth Movement. J Dent Res (2014) 0.81
The effect of antioxidants on the production of pro-inflammatory cytokines and orthodontic tooth movement. Mol Cells (2011) 0.79
Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. J Mater Sci Mater Med (2009) 0.78
Effect of age on regulation of human osteoclast differentiation. J Cell Biochem (2014) 0.78
Effect of bisphosphonates on orthodontic tooth movement-an update. J Clin Diagn Res (2015) 0.78
Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. J Dent Res (2014) 0.76
The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM). Front Physiol (2017) 0.75
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. Dental Press J Orthod (2015) 0.75
A Novel Rat Model of Orthodontic Tooth Movement Using Temporary Skeletal Anchorage Devices: 3D Finite Element Analysis and In Vivo Validation. Int J Dent (2014) 0.75
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc (2005) 4.02
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res (2004) 3.17
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol (2005) 2.03
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer (2003) 1.65
The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res (2001) 1.57
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res (2000) 1.52
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol (2007) 1.50
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. J Bone Miner Res (1999) 1.47
Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. Bone (2006) 1.41
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum (2003) 1.31
Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res (2002) 1.23
Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des (2001) 1.16
The effect of age on tooth movement and mineral density in the alveolar tissues of the rat. Am J Orthod Dentofacial Orthop (1988) 1.08
Osteoclast recruitment to sites of compression in orthodontic tooth movement. Am J Orthod Dentofacial Orthop (2001) 1.06
The effects of exogenous prostaglandins on orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop (1995) 1.03
Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats. Am J Orthod Dentofacial Orthop (1994) 1.03
The effect of prostaglandin E2 and calcium gluconate on orthodontic tooth movement and root resorption in rats. Eur J Orthod (2003) 1.03
Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. J Am Dent Assoc (2005) 1.00
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res (2003) 0.99
Measuring dental drift and orthodontic tooth movement in response to various initial forces in adult rats. Am J Orthod Dentofacial Orthop (1991) 0.99
Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthod Craniofac Res (2006) 0.98
Local RANKL gene transfer to the periodontal tissue accelerates orthodontic tooth movement. Gene Ther (2006) 0.98
Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone (2004) 0.97
Effect of misoprostol, a prostaglandin E1 analog, on orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop (2002) 0.97
Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement. J Dent Res (2004) 0.96
Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats. J Dent Res (1994) 0.95
The effect of force magnitude on extractable bone resorptive activity and cemental cratering in orthodontic tooth movement. J Dent Res (1982) 0.95
Tissue reaction to orthodontic tooth movement in acute and chronic corticosteroid treatment. Orthod Craniofac Res (2004) 0.94
Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci (2002) 0.90
Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. J Dent Res (2006) 0.88
Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab (2004) 0.88
Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech (2005) 0.88
Localization of receptor activator of NFkappaB ligand, RANKL, in periodontal tissues during experimental movement of rat molars. J Electron Microsc (Tokyo) (2001) 0.86
Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength. Calcif Tissue Int (2005) 0.85
Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. J Bone Miner Metab (2005) 0.85
Effects of echistatin and an RGD peptide on orthodontic tooth movement. J Dent Res (2003) 0.83
Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement. J Dent Res (2003) 0.81
Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading. Calcif Tissue Int (2004) 0.80
Involvement of nitric oxide in orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop (2002) 0.79
Anchorage provided during intra-arch distal molar movement: a comparison between the Nance appliance and a fixed frontal bite plane. Angle Orthod (2005) 0.77
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res (2008) 4.82
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res (2009) 4.40
Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol (2005) 3.24
Teriparatide and osseous regeneration in the oral cavity. N Engl J Med (2010) 3.08
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Swallowed and aspirated dental prostheses and instruments in clinical dental practice: a report of five cases and a proposed management algorithm. J Am Dent Assoc (2014) 2.77
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39
The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials (2007) 2.14
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov (2012) 2.07
Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe (2013) 1.89
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. Endocrinology (2005) 1.78
Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol (2009) 1.72
Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res (2009) 1.68
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats. J Bone Miner Res (2010) 1.65
Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am (2005) 1.56
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol (2007) 1.50
Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol (1985) (2008) 1.49
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis (2007) 1.42
TMJ disorders: future innovations in diagnostics and therapeutics. J Dent Educ (2008) 1.40
Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release (2006) 1.40
Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci (2007) 1.39
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum (2009) 1.27
Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther (2004) 1.26
Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol (2007) 1.25
Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv (2006) 1.24
Multiple differentiation capacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev (2009) 1.23
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
Chondrogenic differentiation of human mesenchymal stem cells in three-dimensional alginate gels. Tissue Eng Part A (2008) 1.18
Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opin Biol Ther (2011) 1.17
Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng (2003) 1.16
The bHLH transcription factor HBI1 mediates the trade-off between growth and pathogen-associated molecular pattern-triggered immunity in Arabidopsis. Plant Cell (2014) 1.15
Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol (2005) 1.12
Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomaterials (2011) 1.12
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res (2005) 1.11
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL. J Biol Chem (2010) 1.10
BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther (2005) 1.09
Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am (2006) 1.09
Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng (2006) 1.09
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol (2007) 1.08
Classification, expression pattern, and E3 ligase activity assay of rice U-box-containing proteins. Mol Plant (2008) 1.07
Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplant (2013) 1.07
Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther (2012) 1.06
RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res (2008) 1.06
Endoscopic removal of bile-duct stones by using a rotatable papillotome and a large-balloon dilator in patients with a Billroth II gastrectomy (with video). Gastrointest Endosc (2008) 1.05
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. J Bone Miner Res (2011) 1.05
Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther (2013) 1.05
The SINA E3 ligase OsDIS1 negatively regulates drought response in rice. Plant Physiol (2011) 1.04
Cell- and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol (2011) 1.04
Biomimetic hybrid scaffolds for engineering human tooth-ligament interfaces. Biomaterials (2010) 1.03
Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol (2002) 1.03
Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. I. Immune population distributions. J Appl Physiol (1985) (2003) 1.02
Specific fibronectin fragments as markers of periodontal disease status. J Periodontol (2002) 1.02
Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol (2006) 1.02
Comparative analysis of collagen membranes for the treatment of implant dehiscence defects. Clin Oral Implants Res (2003) 1.02
Image-based, fiber guiding scaffolds: a platform for regenerating tissue interfaces. Tissue Eng Part C Methods (2013) 1.02
The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab (2006) 1.01
Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats. Endocrinology (2011) 1.00
Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000 (2003) 0.99
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res (2003) 0.99
One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. J Bone Miner Res (2009) 0.99
Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci (2007) 0.99
Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS One (2008) 0.98
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. Bone (2009) 0.98
Cementoblast delivery for periodontal tissue engineering. J Periodontol (2004) 0.98
Transient muscle paralysis degrades bone via rapid osteoclastogenesis. FASEB J (2011) 0.97
Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. J Clin Periodontol (2009) 0.97
Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss. Arthritis Res Ther (2006) 0.97
Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial. J Periodontol (2012) 0.96
Quantification of external root resorption by low- vs high-resolution cone-beam computed tomography and periapical radiography: A volumetric and linear analysis. Am J Orthod Dentofacial Orthop (2013) 0.96
Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol (2008) 0.95
Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol (2004) 0.94
Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants. Arthritis Res Ther (2004) 0.94
Bacterial and salivary biomarkers predict the gingival inflammatory profile. J Periodontol (2011) 0.94
Advanced reconstructive technologies for periodontal tissue repair. Periodontol 2000 (2012) 0.94
Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study. J Clin Periodontol (2009) 0.94
Dexamethasone's enhancement of osteoblastic markers in human periodontal ligament cells is associated with inhibition of collagenase expression. Bone (2006) 0.93
Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalphaR and prolongs ERK and Akt/PKB activation. Am J Physiol Cell Physiol (2002) 0.93
Living cellular construct for increasing the width of keratinized gingiva: results from a randomized, within-patient, controlled trial. J Periodontol (2011) 0.93
Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets. J Appl Physiol (1985) (2002) 0.93
Pressure and distortion regulate human mesenchymal stem cell gene expression. Ann Biomed Eng (2009) 0.93
Evaluation of functional dynamics during osseointegration and regeneration associated with oral implants. Clin Oral Implants Res (2010) 0.92
Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther (2009) 0.92
Sclerostin antibody stimulates bone regeneration after experimental periodontitis. J Bone Miner Res (2013) 0.92
Comparative histologic analysis of coronally advanced flap with and without collagen membrane for root coverage. J Periodontol (2002) 0.92
The effect of platelet-rich plasma on the coronally advanced flap root coverage procedure: a pilot human trial. J Periodontol (2005) 0.91
RANKL inhibition: from mice to men (and women). Adv Exp Med Biol (2007) 0.90
Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration. Tissue Eng Part A (2010) 0.90
Novel antibacterial nanofibrous PLLA scaffolds. J Control Release (2010) 0.89
Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease. J Periodontol (2008) 0.88
Immunoglobulin G (IgG) class, but Not IgA or IgM, antibodies to peptides of the Porphyromonas gingivalis chaperone HtpG predict health in subjects with periodontitis by a fluorescence enzyme-linked immunosorbent assay. Clin Vaccine Immunol (2009) 0.88
Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways. Mol Cell Endocrinol (2012) 0.88
Calcium hydroxide promotes cementogenesis and induces cementoblastic differentiation of mesenchymal periodontal ligament cells in a CEMP1- and ERK-dependent manner. Calcif Tissue Int (2010) 0.87